2024-513692-41-00招募中1 期
A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 33
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
AstraZeneca Clinical Study Information Center
Scientific
AstraZeneca AB
研究点 (3)
Loading locations...
相似试验
招募中
4 期
Comparison of effects of baricitinib and sarilumab on arthralgia in patients with rheumatoid arthritisjoint painD001172JPRN-jRCT1031230107Ogasawara Michihiro60
已完成
2 期
SarCaBon: a randomised phase II trial of saracatinib versus placebo for cancer-induced bone paiCancerISRCTN60942134Sheffield Teaching Hospitals NHS Trust (UK)13
招募中
3 期
A study to evaluate the impact on metastases-free survival with the addition of saruparib vs placebo to a standard radiotherapy androgen deprivation regimen in men with high-risk prostate cancer with a BRCA mutation.Prostate Cancer2024-513586-39-00AstraZeneca AB253
尚未招募
不适用
A clinical trial to study the effect of two drugs Sarshap Upanah & Mgso4 Glycerine in abscessCTRI/2019/02/017760PDEAS College of Ayurveda and research centre
招募中
不适用
A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01) (EvoPAR-Breast01)Advanced Breast CancerjRCT2031240096Astrazeneca K.K35